Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma

Abstract

In NVG, IVB treatment can reduce iris and angle neovascularization and inhibits further PAS formation temporarily. Panretinal photocoagulation inhibits neovascularization constantly. Therefore, management of open angle NVG is more feasible with bevacizumab combined with panretinal photocoagulation.